TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/23/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Mark description
The mark consists of a stick figure man with the body shown in dark blue and an orange circle as the head.
Holders
Representatives
Cheryl L. Burbach Erise IP, P.A.
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical, biological, and pharmaceutical preparations for the treatment of viral infections, bacterial infections, cancer, viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock, for the treatment of viral infections, bacterial infections, cancer, viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical, biological, and pharmaceutical preparations for preventing and treating viral, bacterial, and yeast infections; veterinary preparations for pets, cattle, livestock, for preventing and treating viral, bacterial, and yeast infections; medical, biological, and pharmaceutical preparations for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; sanitary preparations for medical purposes; dietary supplements and dietetic preparations adapted for medical purposes; dietetic foods adapted for medical use; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical use; clinical medical reagents
Class 42
Biological research; clinical research in the field of age-related diseases and cancer; medical research; research and development services in the field of pharmaceutical preparations; pharmaceutical products development; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research on the subject of pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceutical product development; development of gene-based medicines; drug discovery services; scientific research in the nature of conducting clinical trials for others relating to pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment being consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following an accidental or terrorist caused release of chemical, biological, radiological or nuclear materials; consulting services in the field of pharmaceutical research; testing of pharmaceuticals being services for assessing the efficiency of pharmaceuticals; pharmaceutical toxicity testing for research purposes; pharmaceutical toxicity analysis services for scientific research purposes; computer services, namely, remote management of the information technology (IT) systems of others for the pharmaceutical and healthcare industries; conducting early evaluations in the field of new pharmaceuticals; providing information about scientific research, namely, the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical research and analysis services; medical and pharmacological research services; scientific services, namely, scientific research in the field of genetics; scientific research for medical purposes in the field of age-related diseases and cancer; medical and scientific research, namely, conducting clinical trials for others; scientific research in the field of genetics; genetic mapping for scientific purposes; DNA screening for scientific research purposes; providing scientific research information in the field of pharmaceuticals for the treatment of medical disorders; technical research in the field of pharmaceutical studies; veterinary research; design and development of computer software relating to the medical field; design and development of computer software relating to healthcare; computer programming in the medical field; scientific computer programming services; providing temporary use of non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; providing temporary use of on-line non-downloadable computer programs on data networks using artificial intelligence (AI) for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; platform as a service (PAAS) featuring computer software platforms using artificial intelligence (AI) for use in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) services featuring software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) featuring software using artificial intelligence (AI) for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data in the life sciences research field, pharmaceutical research, medical research, drug discovery and development; software as a service (SaaS) featuring software using artificial intelligence (AI) for analysis of self-assessment of illnesses; software as a service (SaaS) featuring software using artificial intelligence (AI) for machine learning in the field of healthcare; software as a service (SaaS) featuring health monitoring software; software as a service (SaaS) featuring software for analyzing biological genetic data; technology consultation in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI)
History of USPTO decisions and trademark events.
33 publications found
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/23/2026
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/23/2026
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/23/2026
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/23/2026
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/23/2026
FINAL DECISION TRANSACTION PROCESSED BY IB
04/16/2026
FINAL DISPOSITION NOTICE SENT TO IB
03/28/2026
FINAL DISPOSITION PROCESSED
03/27/2026
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/16/2025
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/22/2025
NEW REPRESENTATIVE AT IB RECEIVED
11/14/2025
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/22/2025
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/22/2025
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/16/2025
REGISTERED-PRINCIPAL REGISTER
09/16/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/29/2025
PUBLISHED FOR OPPOSITION
07/29/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/23/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
06/20/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/01/2025
NEW REPRESENTATIVE AT IB RECEIVED
03/28/2025
REFUSAL PROCESSED BY IB
11/23/2024
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/08/2024
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/05/2024
REFUSAL PROCESSED BY MPU
11/05/2024
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/30/2024
NON-FINAL ACTION WRITTEN
10/29/2024
ASSIGNED TO EXAMINER
10/25/2024
APPLICATION FILING RECEIPT MAILED
06/03/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2024
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/23/2024
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.